[1]
2024. Bimekizumab 4-year Efficacy in High-impact Areas in Moderate to Severe Plaque Psoriasis: Pooled Results from BE BRIGHT. SKIN The Journal of Cutaneous Medicine. 8, 6 (Nov. 2024), s432. DOI:https://doi.org/10.25251/skin.8.supp.432.